Core Viewpoint - Wuxi Shengjing Microelectronics Co., Ltd. has announced a cash dividend distribution plan for the fiscal year 2024, with a proposed cash dividend of 0.1001 CNY per share, amounting to a total distribution of approximately 10.07 million CNY, which represents 43.94% of the net profit attributable to shareholders [1][2][3]. Dividend Distribution Plan - The cash dividend of 0.1001 CNY per share will be distributed to all shareholders registered by the equity registration date [1][2]. - The total number of shares eligible for the dividend is 100,567,367 shares after excluding 99,300 shares held in the company's repurchase account [3]. - The dividend distribution was approved at the annual general meeting held on June 9, 2025 [1]. Relevant Dates - The key dates for the dividend distribution are as follows: - Equity registration date: August 6, 2025 - Last trading day: August 7, 2025 - Ex-dividend date: August 7, 2025 [1][4]. Tax Implications - For individual shareholders holding shares for more than one year, the dividend income is exempt from personal income tax. For those holding shares for less than one month, the full dividend is subject to a 20% tax rate [7]. - Qualified Foreign Institutional Investors (QFII) will have a 10% withholding tax applied to their dividend income, resulting in a net dividend of 0.09009 CNY per share after tax [8][9]. Implementation of Dividend Distribution - The cash dividends will be distributed through the China Securities Depository and Clearing Corporation Limited, Shanghai Branch, to shareholders who have completed designated transactions [6]. - Shareholders who have not completed designated transactions will have their dividends held by the clearing company until the transactions are completed [6].

Core Viewpoint - The legal opinion issued by Guohao Law Firm confirms that Shanghai Honglida Information Technology Co., Ltd.'s differentiated dividend distribution plan complies with relevant laws and regulations, ensuring no harm to the interests of the company and its shareholders [1][4][5]. Group 1: Reasons for Differentiated Dividend - The differentiated dividend is based on the regulations of the Repurchase Rules and the Guidelines for Repurchase, which state that shares in the repurchase account do not have rights to profit distribution [2][3]. - As of September 3, 2024, the company has repurchased a total of 1,301,916 shares through centralized bidding [2]. Group 2: Dividend Distribution Plan - The company plans to distribute a cash dividend of 3.4 yuan (including tax) for every 10 shares based on the total share capital minus the repurchased shares [3][4]. - The total number of shares eligible for profit distribution is 138,698,084 after excluding the repurchased shares from the total share capital of 140,000,000 [4]. Group 3: Calculation Basis for Differentiated Dividend - The reference price for ex-dividend is calculated as (previous closing price - cash dividend) / (1 + change in circulating shares ratio) [4]. - The actual cash dividend distributed is calculated to be approximately 0.33684 yuan per share after considering the total eligible shares [5]. Group 4: Conclusion - The legal opinion concludes that the differentiated dividend distribution aligns with the Company Law, Securities Law, Repurchase Rules, and the company's articles of association, with no adverse effects on the company or its shareholders [5].

Core Viewpoint - Spring Medical (688236) has adjusted its 2024 profit distribution cash dividend total to RMB 18,727,390.80 (including tax), with a cash dividend of RMB 0.049 per share, reflecting a minor change due to share buybacks [2][3][5]. Trading Information Summary - On July 25, Spring Medical's stock closed at RMB 22.4, up 7.49%, with a turnover rate of 1.99%, trading volume of 57,300 shares, and a transaction amount of RMB 128 million [1]. - The fund flow on the same day showed a net outflow of RMB 847.16 million from main funds, accounting for 6.63% of the total transaction amount, while retail investors had a net inflow of RMB 934.27 million, representing 7.31% of the total [2][5]. Company Announcement Summary - Spring Medical announced an adjustment in the total cash dividend for 2024 from RMB 18,752,317.40 (including tax) to RMB 18,727,390.80 (including tax) due to changes in the number of shares participating in the profit distribution [2][5]. - The company will distribute a cash dividend of RMB 0.49 per 10 shares (including tax), with the actual number of shares participating in the distribution being 382,191,649 shares [2][3]. Legal Opinion Summary - A special legal opinion from Beijing Wanshang Tianqin Law Firm confirmed that the differentiated dividend distribution for A-shares complies with relevant laws and regulations, and the impact on the ex-dividend price is minimal, below 1% [4].

Group 1 - The core viewpoint of the article is that Citic Securities has conducted a review of Shanghai Kaisa Biotechnology Co., Ltd.'s differentiated dividend distribution plan for 2024, confirming its compliance with relevant laws and regulations [1][5] - The reason for the differentiated dividend distribution is the company's decision to repurchase shares using its own or raised funds, with a total repurchase amount between RMB 10 million and RMB 20 million [1][2] - As of the date of the review, the company has repurchased 2,341,165 shares, accounting for 0.32% of the total share capital of 721,289,794 shares [2][3] Group 2 - The differentiated dividend plan involves distributing a cash dividend of RMB 4 per 10 shares (including tax) to all shareholders, excluding the repurchased shares [2][3] - The total cash dividend to be distributed is approximately RMB 287.58 million (including tax), based on the adjusted total share capital after excluding repurchased shares [3] - The ex-dividend reference price is calculated to be approximately RMB 46.38 per share, with a minimal impact on the stock price due to the dividend distribution [4][5] Group 3 - The review by Citic Securities concludes that the differentiated dividend distribution plan aligns with the Company Law, Securities Law, and relevant self-regulatory guidelines, ensuring no harm to the interests of the company and its shareholders [5]

Core Viewpoint - The article discusses the special verification opinion regarding the differentiated dividend distribution of Haowei Integrated Circuit (Group) Co., Ltd., confirming that the distribution complies with relevant laws and regulations [1][5]. Group 1: Reasons for Differentiated Dividend - The company has conducted multiple share repurchase plans, with total repurchase amounts ranging from RMB 3 billion to RMB 12 billion, and share prices capped between RMB 85 and RMB 100 per share [1]. - As of the latest report, the company has repurchased a total of 15,134,363 shares, which are held in a dedicated repurchase account and do not participate in the dividend distribution [3][4]. Group 2: Dividend Distribution Details - The proposed dividend distribution is set at RMB 2.20 per 10 shares (including tax), based on a total share capital of 1,217,223,785 shares, excluding the repurchased shares [4]. - The actual number of shares participating in the distribution is 1,202,089,422 shares, leading to a calculated ex-dividend reference price of RMB 125.57 per share [4]. Group 3: Conclusion - The special verification opinion concludes that the differentiated dividend distribution aligns with the Company Law, Securities Law, and self-regulatory guidelines, ensuring no harm to the interests of the company and its shareholders [5].

Core Viewpoint - The legal opinion letter issued by King & Wood Mallesons Shanghai Office confirms that the differentiated profit distribution plan proposed by Jin Jiang International Hotel Co., Ltd. complies with relevant laws and regulations, ensuring no harm to the interests of the company and its shareholders [1][3][7] Group 1: Differentiated Profit Distribution Plan - The differentiated profit distribution plan involves a cash dividend of RMB 3.80 per 10 shares, based on a total share capital of 1,070,044,063 shares, excluding 1,965,760 shares held in the repurchase account [4][6] - The total number of A shares eligible for distribution is 909,453,044 shares after deducting the shares in the repurchase account, while the total number of B shares remains at 156,000,000 shares [5][6] Group 2: Special Ex-Dividend Treatment - The shares in the repurchase account do not participate in profit distribution, as per the regulations outlined in the regulatory guidelines [6] - The ex-dividend reference price is calculated to be RMB 21.83 per share, based on the previous closing price of RMB 22.21 and the cash dividend [6][7] Group 3: Legal Compliance and Conclusion - The legal opinion asserts that the differentiated profit distribution plan adheres to the Company Law, Securities Law, and relevant regulations, with no detrimental effects on the company or its shareholders [3][7] - The opinion letter is intended solely for the purpose of the differentiated profit distribution and cannot be used for any other purpose [3][4]

Core Viewpoint - The legal opinion issued by Beijing Wan Shang Tian Qin Law Firm confirms that the differentiated dividend distribution plan of Beijing Chunli Zhengda Medical Device Co., Ltd. complies with relevant laws and regulations, ensuring no harm to the interests of the company and its shareholders [4][10]. Group 1: Differentiated Dividend Distribution - The differentiated dividend distribution is based on the company's 2024 profit distribution plan, which proposes a cash dividend of 0.49 RMB per 10 shares, with no stock dividends or capital reserve transfers [6][8]. - The total number of shares participating in the distribution is 382,191,649, which includes 287,051,149 A shares and 95,140,500 H shares, after excluding the repurchased shares [8][9]. - The company has repurchased 1,376,851 A shares, accounting for approximately 0.4774% of the total A shares, which do not participate in the dividend distribution [6][8]. Group 2: Legal Compliance and Verification - The law firm conducted thorough verification of the documents and materials provided by the company, ensuring their authenticity and completeness [2][3]. - The legal opinion is strictly based on Chinese laws and regulations, and does not cover any non-legal professional matters such as accounting or finance [3][4]. - The law firm confirms that the differentiated dividend distribution aligns with the provisions of the Company Law, Securities Law, and relevant regulatory guidelines [4][10]. Group 3: Impact on Stock Price - The differentiated dividend distribution is expected to have a minimal impact on the A-share ex-dividend reference price, with the absolute value of the impact being less than 1% [10]. - The calculated A-share ex-dividend reference price is approximately 18.7212 RMB per share, based on the last closing price and the cash dividend [9][10].

Core Viewpoint - The article discusses the differentiated dividend distribution plan of Shanghai United Imaging Healthcare Co., Ltd. for the year 2024, highlighting the rationale, calculation basis, and implications of the plan [1][2][4]. Group 1: Reasons for Differentiated Dividend - The company has approved a share repurchase plan with a total fund of no less than RMB 400 million and no more than RMB 800 million, aimed at employee stock ownership plans or equity incentives [1]. - The repurchased shares do not have rights to profit distribution or capital reserve conversion, necessitating the differentiated dividend distribution for 2024 [2]. Group 2: Differentiated Dividend Plan - The company plans to distribute a cash dividend of RMB 0.80 per 10 shares (tax included) to all shareholders, without capital reserve conversion or bonus shares [2]. - The total number of shares eligible for the dividend is calculated as 820,023,872 shares, leading to an expected total cash dividend of RMB 65,601,909.76 (tax included) [2]. Group 3: Calculation Basis for Dividend - The reference price for ex-dividend is calculated based on the last closing price of RMB 124.84, with the actual cash dividend per share being RMB 0.08 [3]. - The virtual cash dividend per share is approximately RMB 0.0796, leading to a minimal impact on the ex-dividend reference price [4]. Group 4: Sponsor's Review Opinion - The sponsors, CITIC Securities and China International Capital Corporation, confirm that the differentiated dividend distribution complies with relevant laws and regulations, and does not harm the interests of the company or its shareholders [4].

Core Viewpoint - The legal opinion from Beijing Zhonglun Law Firm confirms that Haier Smart Home Co., Ltd.'s differentiated dividend distribution plan for 2024 complies with relevant laws and regulations, ensuring no harm to the interests of the company and its shareholders [8]. Group 1: Differentiated Dividend Distribution - The differentiated dividend distribution is based on the company's 2024 profit distribution plan, which proposes a cash dividend of RMB 9.65 per 10 shares (including tax) for all shareholders, excluding shares held in the repurchase account [5][6]. - As of the date of the legal opinion, the company has repurchased a total of 59,919,870 shares, with 31,481,400 shares held in the repurchase account, which do not participate in the profit distribution [3][4]. Group 2: Impact on Ex-Dividend Price - The actual cash dividend per share is RMB 9.65, and the total number of shares eligible for distribution is 6,194,231,825 shares after excluding repurchased shares [6]. - The ex-dividend reference price calculated based on actual distribution is approximately RMB 23.96 per share, while the virtual distribution reference price is approximately RMB 23.97 per share, indicating a minimal impact of 0.0388% on the ex-dividend price due to the shares in the repurchase account not participating in the dividend [6][7]. Group 3: Legal Compliance - The legal opinion asserts that the differentiated dividend distribution adheres to the Company Law, Securities Law, and other relevant regulations, confirming that it does not infringe upon the rights of the company or its shareholders [8].

Core Viewpoint - The legal opinion issued by Zhejiang Liuhe Law Firm confirms the compliance of the differentiated dividend distribution plan for Caitong Securities Co., Ltd. for the year 2024 with relevant laws and regulations, ensuring no harm to the interests of the company and its shareholders [2][6]. Group 1: Differentiated Dividend Distribution - The differentiated dividend distribution is based on the approval of the 2024 annual profit distribution plan, which includes a cash dividend of 1.10 yuan (tax included) for every 10 shares held by A-share shareholders registered on the equity registration date [4][6]. - The total share capital of the company as of July 16, 2025, is 4,643,760,927 shares, with 40,741,986 shares repurchased and not participating in the dividend distribution [4][5]. - The company plans to maintain the cash dividend per share at 1.10 yuan, adjusting the total distribution amount based on the actual number of shares participating in the distribution [4][5]. Group 2: Legal Compliance - The legal opinion states that the differentiated dividend distribution complies with the Company Law, Securities Law, and relevant regulations from the Shanghai Stock Exchange, ensuring no detriment to the interests of the company and its shareholders [2][6]. - The law firm conducted necessary verifications and reviewed relevant documents to ensure the legality of the differentiated dividend distribution [2][3].